LEQSELVI has shown rapid results in clinical trials, with one-third of patients regaining nearly full scalp hair by Week 24. Additionally, 3% of patients achieved 80% or more scalp coverage in just 8 weeks, addressing a critical unmet need in this therapeutic area. Shares of Sun Pharmaceutical Industries Ltd ended at ₹1,681.45, up by ₹8.95, or 0.54%, on the BSE.
